David A. Mankoff

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Lalitha Shankar, John M. Hoffman, S.L. Bacharach et al. · PubMed · 2006 · 679 citations

Medicine, Nuclear Medicine, Oncology +17

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 418 citations · Full text

Medicine, Oncology, Pharmacology +17

Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer

Hannah M. Linden, S. A. Stekhova, Jeanne M. Link et al. · Journal of Clinical Oncology · 2006 · 393 citations

Medicine, Nuclear Medicine, Oncology +17

Hypoxia and Glucose Metabolism in Malignant Tumors

Joseph G. Rajendran, David A. Mankoff, Finbarr O’Sullivan et al. · Clinical Cancer Research · 2004 · 391 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A definition of molecular imaging.

David A. Mankoff · PubMed · 2007 · 324 citations

Natural Sciences, Cell Biology, Molecular Biology +12